Portfolio on its own behalf

Situation on december 31, 2020
 
COMPANY SHAREH. BUSINESS

RAILWAY INFRASTRUCTURE FUND

www.fif-fsi.be

100% Company that aims at selling the sites that used to belong to the railway infrastructure to real estate developers.

CONGRESPALEIS / PALAIS DES CONGRÈS "SQUARE"

www.square-brussels.eu

100% Congrespaleis/Palais des Congrès organises meetings, congresses, exhibitions, trade shows and events in its buildings in Brussels.
ZEPHYR-FIN 100% This company acquires and manages securities issued by airlines or companies linked to that industry.
CERTI-FED 100% The company has as object the acquisition of equity of companies in which Société fédérale de Participations et d’Investissement has a holding, along with certification of shares.

BMI-SBI

www.bmi-sbi.be

60,07% A specialist subsidiary which co-finances foreign investments by Belgian companies, mainly for SMEs which are growing or show potential for growth.

A CAPITAL CHINA OUTBOUND FUND (Mirror Fund)

www.acapital.hk

50,00% Feeder fund set up with the China Investment Corporation in order to invest in the A Capital China Outbound fund that aims to attract Chinese investors to Europe and especially to Belgium.

BLUEBERRY (SABCA)

www.sabca.be

50,00% Blueberry is a consortium of SFPI and Sabena Aerospace that took over SABCA and combined the activities of both companies in June 2020, thereby creating a strong aerospace industrial group.

SWIMOVE

www.swimove.be

49,00% A new company with a social purpose, founded on the initiative of the VUB. It has the task of managing the renovation and expansion of the VUB swimming pool as well as the operation of a swimming school.

BGF MANAGEMENT

www.belgiangrowthfund.be

49,00% Created in April 2019, the Belgian Growth Fund is a fund of funds inspired by a similar successful model in Denmark, supporting funds that invest in Belgian and international companies with promising prospects and help them grow.

DATANG - FPIM/SFPI VENTURE CAPITAL FUND

www.datang-telecom.com

45,00% Investment fund, which SFPI-FPIM has set up together with the Chinese Datang group in order to promote venture capital in China.

SMARTFIN VENTURES

www.smartfinvc.com

41,89% SmartFin is a fund dedicated to acquiring minority interests in early-stage enterprises active in intelligent new technologies used in the financial sector (‘FinTech’) and also in related technologies such as security, Big Data, artificial intelligence and corporate software.

BELGIAN GROWTH FUND I

www.belgiangrowthfund.be

39,84% Created in April 2019, the Belgian Growth Fund is a fund of funds inspired by a similar successful model in Denmark, supporting funds that invest in Belgian and international companies with promising prospects and help them grow.

BELGIAN INFRASTRUCTURE FUND - I4B

www.infra4be.com

33,33% I4B was established in February 2019 to support the development of Belgian infrastructure and facilities. It has three entities in its capital: SFPI, AG Insurance and Synatom. The fund covers a variety of sectors, such as the energy transition, transport, social infrastructure and telecommunication infrastructure.

BOZAR

www.bozar.be

32,53% This company devises, develops and implements multidisciplinary and integrated cultural programming.
THEODORUS IV 30,42% The Theodorus IV Fund has as its particularity compared to its predecessors the way in which the ULB and the researchers are paid, and in its desire to bring into the capital of investors outside Belgium to enhance the investment policy of Theodorus.

BECENTRAL

www.becentral.org

30,31% BeCentral is a new digital campus located at Brussels Central railway station. The campus was set up jointly by and with support from more than 40 businesses. Its purpose is to rectify the deficit in digital competences and to accelerate the digital transformation in Belgium, among other things so as to maximise the growth potential of the economy and create as many new jobs as possible.

BPOST

www.bpost.be

26,91% This company delivers domestic and international postal services and transports, sorts and distributes parcels, printed matter, periodicals and addressed/non-addressed documents. It also provides financial and banking services.

FORTINO CAPITAL VENTURE II

www.fortinocapital.com

25,32% Established in early 2020, Fortino Capital Ventures II is a follow-on investment fund to Fortino Capital Ventures I Arkif.  Investing in technology companies with high growth potential and those undergoing digital transformation.

BRUSSELS AIRPORT COMPANY

www.brusselsairport.be

25,00% This company holds and manages shares and certificates representing the shares of The Brussels Airport Company.

ACCESSIA PHARMA

www.accessiapharma.com

25,00% Company with a Shared GMP (Good Manufacturing Practice) for the production of clinical and commercial parties.
THEODORUS III 24,69% A university investment fund.

SCALE-UPS

www.scale-ups.eu

24,56% Scale-ups.eu is an initiative aimed at accelerating the development of scale-ups in Europe by bringing them into contact with an extensive network of investors while at the same time promote and accelerate cooperation with high-tech and large companies in its network.

BILOBA
(Ginkgo Fund I)

www.ginkgofund.com

24,27% The purpose of the Luxembourg company is to acquire shares of the Ginkgo Fund. The Ginkgo Fund invests in brownfield redevelopment projects in France and Belgium.

NXTPORT

www.nxtport.com

23,72% NxtPort manages a data platform used to collect, group and then centralise data of the different links in the logistical supply chain related to activities in the Port of Antwerp. The platform is designed to improve the sharing of data, thus enhancing the transparency and efficiency of this process.

THAUMAS "EUROPORTS"

www.euroports.com

23,32% Thaumas is a holding company that was initially established and used as a legal entity to manage the takeover process of the port group Euroports. On the date of the closing of the transaction, it becomes the owner of the shares.

BIOXODES

www.bioxodes.com

23,08% Bioxodes is a company that, starting from studies at the Brussel’s University on the tick saliva, developped a molecule with anticoagulant properties without risk on bleeding.

EXEVIR BIO

www.exevir.com

22,78% ExeVio Bio is a spin-off of the Flemish Institute for Biotechnology (known by the Dutch acronym VIB). It draws on its llama nanobody technology to focus on the design of a therapeutic treatment for COVID-19 and other potential beta coronavirus-related diseases.

PDC LINE PHARMA

www.pdc-line-pharma.com

22,21% This company is a spin-off of the French national blood service l'Etablissement français du sang (EFS). It is active in immuno-oncology, i.e. the production of therapeutic vaccines against cancer. PDC Line Pharma has two products: one in the field of melanomas and one in the field of lungs.

AIR BELGIUM

www.airbelgium.com

22,19% Air Belgium is a Belgian airline company that received its certificate and flying licence in 2018. Air Belgium made its first flight in 2018 on behalf of a third company.

FIDENTIA GREEN BUILDINGS

www.fidentia.be

21,33% Company operating as a fund in order to develop, construct and sell low energy buildings.

LOTERIE NATIONALE

www.loterie-nationale.be

21,28% This company organises public lotteries, betting and competitions.

REGENERO

www.futuregenerations.be

20,74% Established in February 2019, the Regenero impact fund provides unique access to companies that are helping to address today's social and environmental challenges and to advance the regenerative economy through their products and services.
TARA INDIA FUND IV TRUST 20,65% The Tara Fund IV is an Indian investment fund focusing on investment with a societal impact, dedicated to investments in innovative start-ups.

QBIC II FUND ARKIV

www.qbic.be

20,37% Investment Fund specializing in investing in spin-offs of research institutes associated with Gent Universiteit, Vrije Universiteit Brussel and Universiteit of Antwerpen. It will also seek cooperation with the Belgian hospitals.
FUND + 20,18% Fund+ is a limited company whose social purpose is to act as company investment and financing of companies active in the sector of life sciences, especially in technology, development and applications in this field.

EPIMÈDE

www.epimede.com

20,00 % The Epimède Company is a fund established as a “PRICAF” which invests in venture capital in small and medium sized technology companies, mainly in the Walloon Region, allowing them to grow.

VIVES INTER-UNIVERSITY FUND

www.vivesfund.com

20,00% Launched in the summer of 2020, the Vives Inter-University Fund (Vives III) is a multi-sector technology fund that invests in projects with a positive impact on society. The fund invests in spin-offs from UCLouvain [Catholic University of Louvain] or its universities as well as in start-ups.

CIM CAPITAL RESTRUT FUND

www.cimcapital.be

19,90% CIM Capital is an Antwerp-based holding company specialised in corporate restructuring. CIM Capital provides assistance to companies that have encountered difficulties and financial, but also operational, reinforcement.

ADDAX MOTORS

www.addaxmotors.com

18,42% Addax Motors is a manufacturer of light electric commercial vehicles that targets three end markets: municipalities, last mile deliveries and industry. Addax's vehicles offer a more environmentally friendly alternative to traditional vans and are often better suited to specific customer needs.

QBIC FEEDER FUND

www.qbic.be

18,37% Qbic is an inter-university (UGent, UAntwerpen and VUBrussel) investment fund focusing on the transformation of technological breakthroughs into sustainable business

SEEDER FUND

www.seederfund.be

18,29 % Seeder Fund has an innovative approach to better meet the need among Belgian start-ups for early-stage venture capital. This approach allows start-ups to save a lot of time in the first three years of their existence by being able to concentrate on their growth instead of on their short and medium-term financing.

CAPRICORN DIGITAL GROWTH FUND

www.capricorn.be

18,18% Established in June 2019, Capricorn Digital Growth Fund invests in companies active in the ICT ("digital technology") sector in the broadest sense of the term. The fund focuses on "data-driven" companies that use artificial intelligence for applications in healthcare and the digitalisation of business processes.

CALYOS

www.calyos-tm.com

18,07% Calyos is a technology company that designs and manufactures two-phase thermal systems for cooling power electronics and electronic components. Calyos' technology (Loop Heat Pipe) is disruptive and totally passive. It does not require pumps or energy to operate, making it a green, silent, economical and highly reliable solution.

NEWTON BIOCAPITAL I

www.newtonbiocapital.com

17,67% The fund was created in April 2017 as a private Pricaf [investment vehicle for private equity investments] and targets companies active in the treatment of chronic diseases such as inflammatory, neurodegenerative, cardiovascular disease and cancer. The fund is geared to Belgian companies as well as European "early stage" companies such as university spin-offs.

NUCLEIS

www.nucleis.eu

17,20% Nucleis specialises in the production in a GMP environment of radiopharmaceutical medicines for human use (including nuclear and non-nuclear medical imaging). It is the result of a spin-off process of the Cyclotron Research Centre of the University of Liege.

NCARDIA BELGIUM

www.ncardia.com

17,12% Ncardia has developed a process for producing induced pluripotent stem cells (IPSC) and produces cardiac muscle cells or cardiac myocytes. Induced pluripotecy is the 'reprogramming' of a differentiated cell in a stem cell by reactivating the expression of the genes associated with the embryonic stage.

CISSOID

www.cissoid.com

16,86% Cissoid is a company that is active in de field of design and sale of semiconductors and integrated circuits that resists to extreme temperatures. It designs, develops and commercializes these products. The company gives also advise in this line of products and solutions.

SINNOLABS HONG KONG LIMITED

www.sinnolabs.com

16,67% Platform launched in 2016 by Belgian entrepreneurs who have been active in Shangai for many years. Their goal is to help the innovative Belgian SMEs understand the Chinese market and support them in their development in China.

PHARMAFLUIDICS

www.pharmafluidics.com

16,22% This is a spin-off from the Free University of Brussels and is developing a new generation of separation columns for screening molecules in fluids with a complex chemical composition. By commercialising its spearhead technology, the μPAC microchip, PharmaPhluidics wants to make a breakthrough in the world of complex separations and analyses of biological samples such as biopsies.

SCALEFUND II

www.scale-fund.com

15,58% Scalefund II is an investment fund dedicated to the post-seed and pre-scaleup phase, with an investment that can vary between EUR 300,000 and EUR 500,000 for an initial commitment, and the possibility of following it up later. The fund characteristically invests only in projects that have already raised one or more funds, and we know its existing investors.

GOOD HARVEST VENTURES

www.astanor.com

15,41% Astanor's Good Harvest Ventures I fund brings together capital, deep sector knowledge and disruptive technologies to create a food future that is nourishing, regenerative, scalable, reliable and that provides food for all, while contributing to the “net zero” objective. Good Harvest Ventures I was established to invest primarily in equities in early-stage and early-growth technology companies active in the food and agriculture sector.

INVENTURES II

www.inventures.fund

15,36% Inventures II is a “Venture Capital Fund” with Belgian impact, managed by Inventures Investment Partners NV. This fund invests in start-ups and scale-ups in Belgium (and neighboring countries) that fulfill at least 17 sustainable Development goals as mentioned by the United Nations. The fund focuses mainly on education, health, “smart cities”, renewable energy and sustainable food production.

KEBONY AS AND KEBONY BELGIUM

www.kebony.com

15,20% Kebony is originally a Norwegian enhanced wood production company. Its spearhead product is a full-fledged alternative to tropical hardwood produced from fast-growing softwood sourced from sustainably managed forest.

WHITE FUND

www.whitefund.be

15,08% White fund was created in October 2019 and aspires to become the new reference investment fund in Belgium for early stage medtech companies.

CAPRICORN ICT ARKIV

www.capricorn.be

15,06% Investment fund that focuses on young innovative companies active in health care, especially in ICT applications.

THE FACTORY FUND

www.thefaktory.com

14,99% The Faktory II fund aims to provide seed capital to technology (mainly Internet of Things and Software as a Service) companies aiming at global leadership in 2B market niches. Created in December 2019, it invests only in companies that offer a product, not a service, so that it can be deployed globally.

SONACA

www.sonaca.com

14,75% This international group mainly develops, manufactures, assembles and tests aviation and space systems.

ONCO DNA

www.oncodna.com

14,75% The company is active in the genetic and protein characterisation of tissue samples sent for analysis by oncologists. It was incorporated in December 2012 and benefits from strong cooperation with the Institute of Genetic Pathology -- a cooperation that has avoided the need for heavy investment in medical analysis.
PERFORMA CLEANTECH INVESTMENT FUND (Brazil) 14,72% An international investment fund, created in collaboration with the Brazilian development bank BNDES. The fund is active in the sectors of energy efficiency and the treatment and management of wastewater and solid waste, and focusses on innovative and sustainable technologies in Brazil.

9.5 MAGNITUDE VENTURES

www.ninepointfive.vc

14,68% 9.5 Ventures is a corporate venturing fund that invests in companies during their early-stage and scale-up phases in the technology sector. The digital and consumer-centricity aspects, as well as partnerships with large corporate groups, are the DNA of 9.5.

FIDENTIA BELUX INVESTMENTS (Fidentia II)

www.fidentia.be

14,50% Investment fund in office buildings with a green certificate. These buildings are located in the Benelux, France and Germany.

CHINA-BELGIUM TECHNOLOGY INNOVATION INDUSTRY FUND

www.capricorn.be

14,29% Following the signing of an MoU with Wuxi Capital in August 2018 and a letter of intent during the Chinese Premier's visit to Brussels in October 2019, the SFPI [Federal Holding and Investment Company] invested in a new Chinese-Belgian investment fund, the China-Belgium Technology Innovative Industry Fund (CBTIIF), alongside Wuxi Capital and JIC, in early 2019.

V-BIO FUND II

www.v-bio.ventures

13,90% Investment fund focussing on finding, creating and financing young and innovative companies with ambitions in life sciences.

INNOVATION FUND

www.innovationfund.eu

13,80% Innovation Fund is a limited company whose area of activity is to act as investment fund focussed on innovative ‘early stage’ and ‘venture’ companies in the field of the chemical industry through financing, consulting and assistance in policy and management.

PROFINPAR FUND

www.profinpar.com

13,28% Profinpar Fund is a fund of businesses pursuing a partner relationship with family-owned SMEs and their shareholders. What makes Profinpar special is that it links an offer of venture capital to the know-how of its numerous investors. Profinpar Fund wants to act as an active partner and growth catalyst by supporting the transfer or the optimisation of companies.

IN2ACTION CAPITAL OVERFLOW VC

www.in2actioncapital.be

13,19% The founders of the Down2Earth Capital fund, which was set up in 2013 as a fund specialising in buyouts and the provision of growth capital to Belgian SMEs, have set up a new private equity fund: In2Action Capital. It will focus mainly on companies in financial difficulty or in need of strategic reorientation, operating entities that no longer form a core business of a large group and family businesses facing succession issues.

IN2ACTION CAPITAL CV

www.in2actioncapital.be

13,19% The founders of the Down2Earth Capital fund, which was set up in 2013 as a fund specialising in buyouts and the provision of growth capital to Belgian SMEs, have set up a new private equity fund: In2Action Capital. It will focus mainly on companies in financial difficulty or in need of strategic reorientation, operating entities that no longer form a core business of a large group and family businesses facing succession issues.

EPICS THERAPEUTICS

www.epicstherapeutics.com

12,85% Epics Therapeutics is one of the world's first companies in the field of therapeutic RNA epigenetics. It aims to become a leader in the development of small molecules capable of correcting certain physiological imbalances caused by aberrant RNA epigenetic modifications that lead to cancer.

VOLTA VENTURES

www.volta.ventures

12,79% Following the example of its predecessor Volta Ventures I, which was launched in 2014, this fund invests in software and internet companies in the Benelux. The Volta Ventures team aims to acquire stakes in around twenty companies over the next five years. It will focus on innovative start-ups with strong and balanced teams, but also on a unique market position and a scalable business model.

LSP 6

www.lspvc.com

12,33% Created in 2018, LSP 6 is an investment fund active in the field of human health. The fund's objective is to invest in around 15 companies active in the research and development of innovative products and services, mainly in Europe, and to focus on drug development with a balance between early and later stage development projects.

INDUSTRYA FUND

www.industrya.com

11,90% The Industrya fund is dedicated to researching, identifying, supporting, hosting and investing in industrial start-ups and scale-ups. The fund is mainly active in the industrial sectors of energy transition, industry 4.0 and materials and will support start-ups and scale-ups deemed strategic for the development of Belgian and European industry.

CAPRICORN HEALTH TECH FUND

www.capricorn.be

11,89% Innovation Fund is a limited company whose area of activity is to act as investment fund focussed on innovative ‘early stage’ and ‘venture’ companies in the field of the chemical industry through financing, consulting and assistance in policy and management.

ISTAR MEDICAL

www.istarmed.com

11,72% Company that develops eye implants, which is the result from the exploitation of the STAR biomaterial, developed by the University of Washington in Seattle, USA.

VIVES II

www.vivesfund.com

11,68% Vives II is a multi-sectorial UCL associated investment fund for investment in new high-tech companies which, in particular, produce innovative work in the field of ecology.

CAPRICORN SUSTAINABLE CHEMISTRY FUND

www.capricorn.be

11,56% Fund that invests in companies that have developed groundbreaking technology that will be the foundation for new generation, sustainable chemical activity. As well as in innovative chemical transformation processes, focused on efficiency and durability.

REMYND

www.remynd.com

11,07% reMYND is a clinical-stage company developing treatments for Alzheimer's disease, diabetes and other diseases caused by cellular dysfunction, using its own drug discovery platform. reMYND stands out from the competition by seeking new mechanisms that address the underlying causes and regenerate the affected human cells, rather than simply treating the symptoms or slowing the disease.

SYNERGIA MEDICAL

www.synergia-medical.com

11,05% Synergie Medical is a company that focuses on the development and commercialization of active implantable devices. She is working on the development of a neurostimulator for epilepsy that uses optical fibers instead of electrical wires. The intention is to be compatible with magnetic resonance imaging.

FORTINO CAPITAL I ARKIV

www.fortino.be

10,82% Investment fund that invests in technology companies with strong growth potential and in companies undergoing digital transformation, especially in the Benelux.

GINKGO FUND II

www.ginkgofund.com

10,78% Fund active in the acquisition, rehabilitation and development of contaminated or demarcated areas in urban areas in France or Belgium with a view to their return to the real estate market.

INBIOSE

www.inbiose.com

10,41% Inbiose is an industrial biotechnology company that was incorporated as a spin-off from Ghent University in 2013. It produces complex sugars by means of fermentation deploying specific micro-organisms by means of a unique (and patented) technology platform, GlycoActives.

AUXIN SURGERY

www.auxin.eu

10,03% The company's mission is to combine a chemical molecule (MESNA, a UCB molecule) with traditional surgical dissection instruments to offer a simple, inexpensive solution for the surgeon, which has been registered as a class III medical device in the EU, and which facilitates the removal of tissue without damaging the surrounding healthy tissue, without any significant side effects, and with a low likelihood of the "unhealthy" tissue reappearing.

TEXERE BIOTECH

www.texerebiotech.com

10,00% Texere's vocation is to offer material for bone reconstruction and repair surgery that allows "bone allograft from human tissue". The central idea there is to start from the surgical residues that are the heads of femurs and  to propose a model of treatment, cutting and conservation of these heads so as to make them supports for the resumption of the bone graft.

BIOQUBE FACTORY FUND

www.bioqubeventures.com

10,00% The Bioqube Factory Fund was set up by three partners (Nico Vandervelpen, Debora Dumont and Dirk Reyn) who started supervising promising R&D projects in 2016 at the Janssen Pharmaceutica site in Beerse. They want to continue to build on the knowledge gained and successes achieved by attracting additional funding, so that they have sufficient financial capacity to focus on the development of the Belgian life sciences ecosystem.

NORMANDY HADRONTHERAPY/NHA (IBA)

www.iba-worldwide.com

9,77% The technological solution proposed by Normandy Hadrontherapy aims to make hadrontherapy (proton therapy and carbon beam treatment) more accessible to clinical treatment centres. The technological solution proposed by NHa aims to replace the synchrotron with an isochronous cyclotron, which is a more compact piece of equipment, significantly less expensive and easier to operate and maintain than the synchrotons currently in use.

HERAN HEALTH TECH FUND I COMMV

www.heranpartners.com

9,68% The Heran HealthTec Fund I is one of the most specialised funds in the Belgian venture capital sector. It invests exclusively in health tech, i.e. in companies at the crossroads between IT and healthcare. These are mainly software solutions that help to analyse and/or manage medical data in the different phases of healthcare. Artificial intelligence is frequently used.

ENDO TOOLS THERAPEUTICS

www.endotools.be

9,12% Endo Tools Therapeutics (ETT) focuses on the fight against obesity by providing a procedure performable by a gastroenterologist so as to reduce the stomach by suturing its inner wall (no operation).

MAISON DE LA RADIO FLAGEY / FLAGEY OMROEPGEBOUW

www.flagey.be

9,11% The company manages spaces intended for cultural activities and houses five studios that vary in size and function.

VESALIUS BIOCAPITAL III

www.vesaliusbiocapital.com

8,92% Vesalius Biocapital III was established as a European venture capital fund in the life sciences field. The fund has set itself the goal of building up a balanced portfolio consisting of between 10 and 12 companies that develop new medicines, diagnostics, medical devices and applications for digital healthcare.

MIRACOR MEDICAL

www.miracormedical.com

8,77% Miracor is active in the medical devices sector. In particular it has developed a technique now being used to treat heart infarcts to ensure that fewer heart cells die in the heart’s left-hand chamber. This prevents repeat heart failures which typically occur among 25% of all treated patients.

IMEC.XPAND

www.imecxpand.com

8,56% IMEC.Xpand is a new investment fund focusing on young innovative companies. It combines all the advantages of traditional venture capital, corporate venture capital and technology transfers. The fund concentrates on businesses that want to be part of the next wave of innovation driven by nano-electronics in smart applications for a sustainable society.

CHINA BELGIUM DIRECT EQUITY INVESTMENT FUND (CBDEIF)

www.hffund.com.cn

8,50% The investment fund invests in Chinese and Belgian companies which are established in China, or which want to set up in China.

SEQUANA MEDICAL

www.sequanamedical.com

8,22% Sequana Medical has developed an innovative implantable pump, patented and approved in the EU for treatment of fluid accumulations in the abdominal cavity. The pump can be implanted in patients with severe liver disease and/ or cancer to regulate the moisture balance in the human body, which makes the patient’s quality of life better.

CAPITAL-E II ARKIV

www.capital-e.com

8,04% Capital E-II is a limited company acting as a venture capital fund with primary focus on micro/nano-electronics and advanced materials for new technologies.

COMET TRAITEMENTS

www.cometgroup.be

7,26% Processing and recycling shredder waste and other industrial waste.

BONE THERAPEUTICS

www.bonetherapeutics.com

7,07% The company is active in bone cell therapy.

COMET SAMBRE

www.cometgroup.be

7,03% The company is active in recycling ferrous and non-ferrous metals for the preparation and sale of secondary raw materials designed for the steel and metal industries.

NANOCYL

www.nanocyl.com

6,97% The company has as its aim the design, development, production and marketing of carbon nanotubes and carbon nanotubes formulated products.

IMCYSE

www.imcyse.com

6,70% Imcyse is a biotechnology company founded in 2010 by Professor Saint-Remy (spin-off of the KU Leuven [Catholic University of Leuven). It develops innovative curative therapies in the field of chronic inflammatory and autoimmune diseases and allergic pathologies.

VESALIUS BIOCAPITAL I

www.vesaliusbiocapital.com

6,67% Venture capital fund that invests in life science companies creating innovative cutting-edge technologies.

V-BIO VENTURES FUND I ARKIV

www.v-bio.ventures

6,59% Investment fund focussing on finding, creating and financing young and innovative companies with ambitions in life sciences.

ASIT BIOTECH

www.biotechtools.fr

6,18% Biopharmaceutical company engaged in the development and commercialization of new drugs for respiratory and food allergies.

MINORYX THERAPEUTICS

www.minoryx.com

6,12 Minoryx Therapeutics is a Spanish biotech company that focuses its research on the development of treatments against orphan diseases affecting the central nervous system. The company developed a molecule that has been shown to be safe and effective in humans in the context of a genetic neurodegenerative disorder.

FOMCAP IV PRIVAK / FORCE OVER MASS

www.fomcap.com

5,39% FOMCAP IV is the fourth fund of the London-based venture capitalist Force Over Mass. The fund invests in very young European growth companies (seed and series A) in the following sectors: fintech, artificial intelligence, software as a service and industry 4.0.

UNIVERCELLS

www.univercells.com

4,89% Univercells was founded in 2013 in Gosselies to make biologics available and affordable for everyone. As a provider of innovative bioproduction platforms and solutions, it focuses on increasing the availability of affordable biologics.

RX/SEAPORT

www.rxseaport.eu

4,63% RX/SeaPort was established to prepare the port of the administrative changes due to the Brexit. The result is that the physical movement of goods is not interrupted by the modified administration and that the competitive position of the port Zeebrugge is strengthened.

EURONEXT

www.euronext.com

4,50% Platform for the centralization of capital markets for Belgian companies.

ITINERIS

www.itineris.net

4,26% Itineris' UMAX software enables utilities (e.g. water and electricity) to manage their interactions with customers. The most important module is the billing system, but the possibilities of the software are much broader.

CHAPELLE MUSICALE / MUZIEKKAPEL

musicchapel.org

3,55% Chapelle Musicale/Muziekkapel is a limited company with a social objective active in 4 sectors : real estate, hotel business, catering at concerts, provision of concert and receptions areas for others.

UNIFLY

www.unifly.aero

3,50% Unifly has developed a platform for the exchange of information between drone pilots, authorities and airspace users (below 500 feet).

EUROCLEAR

www.euroclear.com

3,07 Euroclear is a global player in the financial post-trade industry (clearing and settlement) based in Brussels. It’s a critical ICT infrastructure within the financial sector. The SFPI is the first shareholder who is not a customer of Euroclear.
SUSTAINABLE ANCHORAGE 2,92% CVBA holds and manages, on behalf of the founders and small Belgian investors, IBA’s shares to ensure its Belgian anchorage.

BEFIMMO

www.befimmo.be

2,46% Befimmo is a real estate investment trust, mainly in the office market, focussing on the Brussels area. One of its largest customers is the Belgian government, which has generally concluded long-term lease contracts with the company.

UNIFIED POST

www.unifiedpost.com

2,37% The Fintech company Unified Post Group, located in La Hulpe, was founded in 2001 and focuses on optimizing the electronic processing of flow invoices and other professional documents. The company distinguishes itself by acting as a one stop shop for its customers (unique platform) and by providing pre-configurated solutions for each sector.

FLUXYS

www.fluxys.com

2,13% The company is the network operator for transport and storage of gas in Belgium and abroad. Its business concerns transportation, storage and freight, including a LNG on-site facility shipping out of Zeebrugge.

BIODISCOVERY 5

www.palico.com

2,04% Biodiscovery 5 is the fifth generation of the Biodiscovery fund, which invests in developing therapeutic products and medical/diagnostic devices. The fund is made up of experts in the biosciences sector, with the aim of offering a financial product that provides simple but well thought-out access to the sector. Biodiscovery estimates the risks, time and resources necessary to develop innovative projects up to the crucial phases of value creation.

SAFRAN AERO BOOSTERS

www.safran-aero-boosters.com

1,78% The company mainly develops, manufactures and assembles products for aeronautical and space systems.

ITEOS THERAPEUTICS

www.iteostherapeutics.com

1,40% iTeos Therapeutics is a common spin-off of het Ludwig Institute for Cancer Research (L.I.C.R.) and the Duve Institute of the Université Catholique de Louvain (U.C.L.). The goal is to combine their expertise in immunotherapy and tumor immunology for the development of innovative anti-cancer treatments.

NYXOAH

www.nyxoah.com

0,55% Founded in 2009, Nyxoah is a Belgian medtech company that develops neuro-stimulation for the fight against sleep apnoea. It has developed a system called Genio that consists of implanting a stimulator in the tongue muscle to activate it when the tongue retracts to the back of the palate and obstructs the airway.

AVANTIUM HOLDING

www.avantium.com

0,36% Dutch company dedicated to the development and commercialization of renewable chemical solutions through the development of processes and sustainable products based on biomaterials.

BNP PARIBAS

www.bnpparibas.com

0,29%  

BIOCARTIS GROUP

www.biocartis.com

0,29% Specialized group in the development of molecular diagnostic systems.

ION BEAM APPLICATIONS (IBA)

www.iba-worldwide.com

0,15% A world leader in diagnosis of cancer cases (dosimetry) as well as the development of innovative tools to treat them via proton therapy.

WELLINGTON PARTNER LIFE SCIENCES V GmbH (EIF)

www.wellington-partners.com

0,01% Wellington Partners Technology is a leading European venture capital firm specialising in investments in early- and growth-stage technology and life science companies.

SWDE

www.swde.be

0,01% Wallonian water company, which supplies 70% of the population and businesses in this region.

ASCO INDUSTRIES

www.asco.be

0,00% Company specialised in design and manufacture of mechanical assemblies and major functional components for the aerospace industry.

BRUSSELS AIRLINES

www.brusselsairlines.com

0,00% The belgian airlines company.

SABENA AEROSPACE ENGINEERING

www.sabena-aerospace.com

0,00% Sabena Aerospace Engineering is a company active in airplanes repair and maintenance for airlines companies as well as for government operators / defense.

SKEYES / Skeye Drone

www.skeyes.be

0,00% Created in February 2020, SkeyDrone is a separate entity from Skeyes (the Belgian air traffic controller) whose object is to enable the development and marketing of unmanned traffic management (UTM) services.